Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

Cited In for PubMed (Select 15466382)

1.

DNA methylation and apoptosis resistance in cancer cells.

Hervouet E, Cheray M, Vallette FM, Cartron PF.

Cells. 2013 Jul 18;2(3):545-73. doi: 10.3390/cells2030545.

2.

DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma.

Martínez R, Carmona FJ, Vizoso M, Rohde V, Kirsch M, Schackert G, Ropero S, Paulus W, Barrantes A, Gomez A, Esteller M.

BMC Cancer. 2014 Mar 20;14:213. doi: 10.1186/1471-2407-14-213.

3.

Personalized treatment strategies in glioblastoma: MGMT promoter methylation status.

Thon N, Kreth S, Kreth FW.

Onco Targets Ther. 2013 Sep 27;6:1363-72. doi: 10.2147/OTT.S50208. Review.

4.

5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft.

Borodovsky A, Salmasi V, Turcan S, Fabius AW, Baia GS, Eberhart CG, Weingart JD, Gallia GL, Baylin SB, Chan TA, Riggins GJ.

Oncotarget. 2013 Oct;4(10):1737-47.

5.

Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis.

Drexler SK, Bonsignore L, Masin M, Tardivel A, Jackstadt R, Hermeking H, Schneider P, Gross O, Tschopp J, Yazdi AS.

Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18384-9. doi: 10.1073/pnas.1209171109. Epub 2012 Oct 22.

6.

Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma.

Liu W, Luo Y, Dunn JH, Norris DA, Dinarello CA, Fujita M.

J Invest Dermatol. 2013 Feb;133(2):518-27. doi: 10.1038/jid.2012.317. Epub 2012 Aug 30.

7.

Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events.

Martínez R.

J Signal Transduct. 2012;2012:519807. doi: 10.1155/2012/519807. Epub 2012 Jun 18.

8.

Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma.

Lin N, Di C, Bortoff K, Fu J, Truszkowski P, Killela P, Duncan C, McLendon R, Bigner D, Gregory S, Adamson DC.

Mol Cancer Res. 2012 Feb;10(2):208-17. doi: 10.1158/1541-7786.MCR-10-0109. Epub 2012 Jan 12.

9.

MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.

Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, Wu M, Li G.

Mol Cancer. 2011 Sep 30;10:124. doi: 10.1186/1476-4598-10-124.

10.

Structural and functional profiling of the human histone methyltransferase SMYD3.

Foreman KW, Brown M, Park F, Emtage S, Harriss J, Das C, Zhu L, Crew A, Arnold L, Shaaban S, Tucker P.

PLoS One. 2011;6(7):e22290. doi: 10.1371/journal.pone.0022290. Epub 2011 Jul 14.

11.

Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.

Zhu D, Hunter SB, Vertino PM, Van Meir EG.

Cancer Res. 2011 Sep 1;71(17):5859-70. doi: 10.1158/0008-5472.CAN-11-1157. Epub 2011 Jul 1.

12.

DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines.

Kadowaki M, Yoshioka H, Kamitani H, Watanabe T, Wade PA, Eling TE.

Int J Cancer. 2012 Jan 15;130(2):267-77. doi: 10.1002/ijc.26082. Epub 2011 May 25.

13.
14.

DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.

Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, Nelson HH, Stokoe D, Wiemels JL, Chang SM, Prados MD, Tihan T, Vandenberg SR, Kelsey KT, Berger MS, Wiencke JK.

Neuro Oncol. 2011 Mar;13(3):280-9. doi: 10.1093/neuonc/noq190.

15.

SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation.

Kapoor-Vazirani P, Kagey JD, Vertino PM.

Mol Cell Biol. 2011 Apr;31(8):1594-609. doi: 10.1128/MCB.00524-10. Epub 2011 Feb 14.

16.

DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma.

Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, Wiemels JL, Nelson HH, Karagas MR, Wrensch MR, Kelsey KT, Wiencke JK.

J Natl Cancer Inst. 2011 Jan 19;103(2):143-53. doi: 10.1093/jnci/djq497. Epub 2010 Dec 16.

17.

Genomic profiling of C/EBPβ2 transformed mammary epithelial cells: a role for nuclear interleukin-1β.

Russell A, Boone B, Jiang A, Sealy L.

Cancer Biol Ther. 2010 Sep 1;10(5):509-19. doi: 10.4161/cbt.10.5.12725. Epub 2010 Sep 21.

18.

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RG, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, Ding L, Wilson RK, Van Den Berg D, Shen H, Bengtsson H, Neuvial P, Cope LM, Buckley J, Herman JG, Baylin SB, Laird PW, Aldape K; Cancer Genome Atlas Research Network.

Cancer Cell. 2010 May 18;17(5):510-22. doi: 10.1016/j.ccr.2010.03.017. Epub 2010 Apr 15.

19.

Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.

Vladimirova V, Mikeska T, Waha A, Soerensen N, Xu J, Reynolds PC, Pietsch T.

Neoplasia. 2009 Jul;11(7):700-11.

20.

Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development.

Bax DA, Little SE, Gaspar N, Perryman L, Marshall L, Viana-Pereira M, Jones TA, Williams RD, Grigoriadis A, Vassal G, Workman P, Sheer D, Reis RM, Pearson AD, Hargrave D, Jones C.

PLoS One. 2009;4(4):e5209. doi: 10.1371/journal.pone.0005209. Epub 2009 Apr 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk